Masimo (MASI) Cash from Financing Activities (2009 - 2026)

Masimo's (MASI) quarterly Cash from Financing Activities came in at -$70.2 million in Q2 2026, down 49.36% year-on-year from -$138.6 million in Q2 2025, and up 67.29% quarter-over-quarter from -$214.6 million in Q1 2026.

Masimo (MASI) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Masimo's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$70.2 million for Q2 2026.

  • On a quarterly basis, Cash from Financing Activities fell 49.36% year-over-year to -$70.2 million in Q2 2026; TTM through Apr 2026 was -$541.3 million, a 269.49% decrease from a year earlier, with the FY2026 full-year figure at -$518.1 million, down 312.5% from the prior year.
  • Cash from Financing Activities climbed to -$70.2 million in Q2 2026 per MASI's latest filing, from -$214.6 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $518.0 million in Q3 2022 and bottomed at -$215.8 million in Q3 2025.
  • The 5-year median for Cash from Financing Activities is -$30.6 million (2023), against an average of -$23.7 million.
  • Across the five-year window, Cash from Financing Activities surged 101.99% in 2024 and plunged 21560.0% in 2026, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$4.7 million in 2022, then sank by 968.09% to -$50.2 million in 2023, then jumped by 101.99% to $1.0 million in 2024, then plunged by 21680.0% to -$215.8 million in 2025, then jumped by 67.47% to -$70.2 million in 2026.
  • Per Business Quant, the three latest MASI Cash from Financing Activities figures stand at -$70.2 million (Q2 2026), -$214.6 million (Q1 2026), and -$215.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Masimo 9.39 Bn 9.27 Bn 250.80 Mn -70.20 Mn

Historic Data

Download Data
DateValue
Apr 4, 2026 -70.20 Mn
Apr 4, 2026 -70.20 Mn
Jan 3, 2026 -214.60 Mn
Jan 3, 2026 -214.60 Mn
Sep 27, 2025 -215.80 Mn
Sep 27, 2025 -215.80 Mn
Jun 28, 2025 -40.70 Mn
Jun 28, 2025 -40.70 Mn
Mar 29, 2025 -47.00 Mn
Mar 29, 2025 -47.00 Mn
Dec 28, 2024 1.00 Mn
Dec 28, 2024 1.00 Mn
Sep 28, 2024 -9.10 Mn
Sep 28, 2024 -9.10 Mn
Jun 29, 2024 -91.40 Mn
Jun 29, 2024 -91.40 Mn
Mar 30, 2024 -26.10 Mn
Mar 30, 2024 -26.10 Mn
Dec 30, 2023 -50.20 Mn
Dec 30, 2023 -50.20 Mn